

Marc Tessier-Lavigne
Neuroscientist and biotech executive who is CEO of Xaira (Zara) Therapeutics, with a career spanning faculty positions and leadership roles at Genentech, Rockefeller University, and Stanford; now leading efforts to apply AI to drug discovery and protein design.


